Skip to main content
Erschienen in: Lung 2/2018

07.12.2017 | Lung Images

Lung Image: Doege–Potter Syndrome

verfasst von: Sami Karapolat, Kubra Nur Seyis, Alaaddin Buran, Atila Turkyilmaz, Safak Ersoz, Celal Tekinbas

Erschienen in: Lung | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Excerpt

A 37-year-old male patient presented to an external clinic reporting dyspnea, fatigue, dizziness, and intermittent episodes of syncope. Upon blood testing, he was found to have hypoglycemia. His anamnesis revealed a surgical procedure and radiotherapy was performed 6 years prior due to a solitary fibrous tumor in his right hemithorax. He had no history of diabetes or medication at all. The patient was somnolent and his blood pressure was 125/80 mmHg, pulse was 95 bpm, and breathing rate was 19 breaths/min. Upon auscultation, no respiratory sounds were heard in the right hemithorax. His blood glucose level was approximately 50 mg/dL and his serum insulin level was 3.4 μU/mL. An intravenous infusion of 50% glucose was performed in an attempt to keep the patient’s blood glucose level within normal limits. Upon chest X-ray, opacity was observed in his right hemithorax. During thoracic tomography, a giant heterogeneous mass was seen in his right hemithorax (Fig. 1). No FDG uptake was observed in PET–CT scans (Fig. 2). The patient was reported to have a solitary fibrous tumor following a transthoracic fine-needle aspiration biopsy. A total excision of the mass and pleura with right redo posterolateral thoracotomy was performed next (Fig. 3). The patient’s blood glucose level remained within normal limits in the postoperative period. He was discharged on postoperative day 8. Macroscopic examination of the specimen revealed that it had well-circumscribed, smooth-surfaced, and capsulated large lobular masses. Following a histopathological examination, the patient was diagnosed with a malignant solitary fibrous tumor of the pleura with pleomorphism and high cellularity (Fig. 4). After a year of follow-up visits, the patient was still asymptomatic. …
Literatur
1.
Zurück zum Zitat Jang JG, Chung JH, Hong KS, Ahn JH, Lee JY, Jo JH, Lee DW, Shin KC, Lee KH, Kim MJ, Lee JC, Lee JH, Lee JK (2015) A case of solitary fibrous pleura tumor associated with severe hypoglycemia: Doege-Potter syndrome. Tuberc Respir Dis 78(2):120–124CrossRef Jang JG, Chung JH, Hong KS, Ahn JH, Lee JY, Jo JH, Lee DW, Shin KC, Lee KH, Kim MJ, Lee JC, Lee JH, Lee JK (2015) A case of solitary fibrous pleura tumor associated with severe hypoglycemia: Doege-Potter syndrome. Tuberc Respir Dis 78(2):120–124CrossRef
2.
Zurück zum Zitat Degnan AJ, Lee KK, Minervini MI, Borhani AA (2016) Metastatic extrapleural malignant solitary fibrous tumor presenting with hypoglycemia (Doege-Potter syndrome). Radiol Case Rep 12(1):113–119CrossRefPubMedPubMedCentral Degnan AJ, Lee KK, Minervini MI, Borhani AA (2016) Metastatic extrapleural malignant solitary fibrous tumor presenting with hypoglycemia (Doege-Potter syndrome). Radiol Case Rep 12(1):113–119CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Villemain A, Menard O, Mandry D, Siat J, Vignaud JM, Martinet Y, Tiotiu A (2017) Paraneoplastic hypoglycemia: the hopes of pathophysiological documentation. Rev Pneumol Clin. 73(3):140–145CrossRefPubMed Villemain A, Menard O, Mandry D, Siat J, Vignaud JM, Martinet Y, Tiotiu A (2017) Paraneoplastic hypoglycemia: the hopes of pathophysiological documentation. Rev Pneumol Clin. 73(3):140–145CrossRefPubMed
Metadaten
Titel
Lung Image: Doege–Potter Syndrome
verfasst von
Sami Karapolat
Kubra Nur Seyis
Alaaddin Buran
Atila Turkyilmaz
Safak Ersoz
Celal Tekinbas
Publikationsdatum
07.12.2017
Verlag
Springer US
Erschienen in
Lung / Ausgabe 2/2018
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-017-0078-2

Weitere Artikel der Ausgabe 2/2018

Lung 2/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.